Determination of raltegravir and raltegravir glucuronide in human plasma and urine by LC-MS/MS with application in a maternal-fetal pharmacokinetic study (2020)
- Authors:
- USP affiliated authors: DUARTE, GERALDO - FMRP ; LANCHOTE, VERA LUCIA - FCFRP ; PEREIRA, MARIA PAULA MARQUES - FCFRP ; MOREIRA, FERNANDA DE LIMA - FCFRP
- Unidades: FMRP; FCFRP
- DOI: 10.1016/j.jpba.2019.112838
- Subjects: FÁRMACOS; ANTIRRETROVIRAIS; GRAVIDEZ
- Keywords: Raltegravir; Raltegravir glucoronide; LC-MS/MS; Pregnancy
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Journal of Pharmaceutical and Biomedical Analysis
- ISSN: 0731-7085
- Volume/Número/Paginação/Ano: v. 177, art. 112838, [9], 2020
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
MOREIRA, Fernanda de Lima et al. Determination of raltegravir and raltegravir glucuronide in human plasma and urine by LC-MS/MS with application in a maternal-fetal pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis, v. 177, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2019.112838. Acesso em: 03 jun. 2024. -
APA
Moreira, F. de L., Marques, M. P., Duarte, G., & Lanchote, V. L. (2020). Determination of raltegravir and raltegravir glucuronide in human plasma and urine by LC-MS/MS with application in a maternal-fetal pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis, 177. doi:10.1016/j.jpba.2019.112838 -
NLM
Moreira F de L, Marques MP, Duarte G, Lanchote VL. Determination of raltegravir and raltegravir glucuronide in human plasma and urine by LC-MS/MS with application in a maternal-fetal pharmacokinetic study [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 177[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.jpba.2019.112838 -
Vancouver
Moreira F de L, Marques MP, Duarte G, Lanchote VL. Determination of raltegravir and raltegravir glucuronide in human plasma and urine by LC-MS/MS with application in a maternal-fetal pharmacokinetic study [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 177[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.jpba.2019.112838 - A background subtraction approach for determination of endogenous cortisol and 6β-hydroxycortisol in urine by UPLC-MS/MS with application in a within-day variability study in HIV-infected pregnant women
- Influence of gasoline inhalation on the enantioselective pharmacokinetics of fluoxetine in rats
- Analysis of ibuprofen enantiomers in rat plasma by liquid chromatography with tandem mass spectrometry
- P-Glycoprotein and organic anion transporter polypeptide 1B/breast cancer resistance protein drug transporter activity in pregnant women living with HIV
- Impact of Plasmodium vivax malaria and antimalarial treatment on cytochrome P450 activity in Brazilian patients
- Pharmacokinetics and placental transfer of bupivacaine enantiomers in HIV-infected parturient women on antiretroviral therapy
- A pilot study of the maternal-fetal pharmacokinetics of furosemide in plasma, urine, and amniotic fluid of hypertensive parturient women under cesarean section
- Distribuição transplacentária da lidocaína e seu metabólito na assistência anestésica via peridural de gestantes com diabetes mellitus gestacional
- Analysis of bupivacaine enantiomers in plasma as total and unbound concentrations using LC-MS/MS:: application in a pharmacokinetic study of a parturient with placental transfer
- Nonrelevant pharmacokinetic drug-drug interaction between furosemide and pindolol enantiomers in hypertensive parturient women [Carta]
Informações sobre o DOI: 10.1016/j.jpba.2019.112838 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 | 003005404.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
